Ascendis Pharma ASMEX:ASNDN 37 Market Cap is MXN236,440 Mil as of Jun. 25, 2026. GuruFocus rates MEX:ASNDN with a GF Score™ of 37/100. The stock has 1 warning sign investors should review. Among 1,431 Biotechnology companies, Ascendis Pharma AS ranks better than 98.6% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Ascendis Pharma AS's share price for the quarter that ended in Mar. 2026 was MXN3851.44. Ascendis Pharma AS's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 61 Mil. Therefore, Ascendis Pharma AS's market cap for the quarter that ended in Mar. 2026 was MXN236,451 Mil.
Ascendis Pharma AS's quarterly market cap
increased
from Sep. 2025 (MXN224,718 Mil) to Dec. 2025 (MXN238,240 Mil) but then
declined
from Dec. 2025 (MXN238,240 Mil) to Mar. 2026 (MXN236,451 Mil).
Ascendis Pharma AS's annual market cap
increased
from Dec. 2023 (MXN119,739 Mil) to Dec. 2024 (MXN156,432 Mil) and
increased
from Dec. 2024 (MXN156,432 Mil) to Dec. 2025 (MXN238,240 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Ascendis Pharma AS's Enterprise Value for Today is MXN242,902 Mil.
Ascendis Pharma AS (MEX:ASNDN) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Ascendis Pharma AS Market Cap Related Terms
Ascendis Pharma AS Market Cap Historical Data
* Premium members only.
The historical data trend for Ascendis Pharma AS's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:ASNDN vs SMMT, BBIO, JAZZ: Market Cap Comparison
For the Biotechnology subindustry, Ascendis Pharma AS's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ascendis Pharma AS Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ascendis Pharma AS's Market Cap distribution charts can be found below:
* The bar in red indicates where Ascendis Pharma AS's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Ascendis Pharma AS's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ascendis Pharma AS (MEX:ASNDN) has a Market Cap of MXN236,440 Mil as of Jun. 25, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Ascendis Pharma AS and its competitors. According to the industry distribution chart, Ascendis Pharma AS ranks #20 out of 1431 companies in the Biotechnology industry, placing it in the top 1.4%.
Is Ascendis Pharma AS's Market Cap too high?
Ascendis Pharma AS's current Market Cap is MXN236,440 Mil. Based on the distribution chart, Ascendis Pharma AS ranks #20 out of 1431 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Ascendis Pharma AS has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Ascendis Pharma AS's Market Cap compare to SMMT and BBIO?
According to the Biotechnology industry distribution chart, Ascendis Pharma AS ranks #20 out of 1431 companies for Market Cap. This places Ascendis Pharma AS in the top 1% of its industry — outperforming the majority of peers. The industry median Market Cap is 117.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 117.63, based on 1,431 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Ascendis Pharma AS and its competitors. For the Biotechnology industry, the median Market Cap is 117.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ascendis Pharma AS's current Market Cap is MXN236,440 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascendis Pharma AS stock overvalued right now?
Ascendis Pharma AS (MEX:ASNDN) has a current Market Cap of MXN236,440 Mil. The current Market Cap is MXN236,440 Mil. Ascendis Pharma AS's overall GF Score™ is 37/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Ascendis Pharma AS (MEX:ASNDN), the current Market Cap is MXN236,440 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
37GF Score
Get the complete analysis for MEX:ASNDN
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ASNDN has been successfully added to your 
